Benign biliary strictures refractory to standard bilioplasty
treated using polydoxanone biodegradable biliary stents:
retrospective multicentric data analysis on 107 patients

J 2016

Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients

MAURI, G., C. MICHELOZZI, F. MELCHIORRE, D. PORETTI, V. PEDICINI et. al.

Basic information

Original name

Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients

Authors

MAURI, G. (380 Italy), C. MICHELOZZI (380 Italy), F. MELCHIORRE (380 Italy), D. PORETTI (380 Italy), V. PEDICINI (380 Italy), M. SALVETTI (380 Italy), E. CRIADO (724 Spain), J.F. FAGES (724 Spain), MA DE GREGORIO (724 Spain), A. LABORDA (724 Spain), L.M. SONFIENZA (380 Italy), G. CORNALBA (380 Italy), L. MONFARDINI (380 Italy), Jiří PÁNEK (203 Czech Republic, belonging to the institution), Tomáš ANDRAŠINA (703 Slovakia, guarantor, belonging to the institution) and M. GIMENEZ (32 Argentina)

Edition

European Radiology, New York, Springer, 2016, 0938-7994

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.967

RIV identification code

RIV/00216224:14110/16:00093917

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s00330-016-4278-6

UT WoS

000385248600031

Keywords in English

Biliary stricture; Percutaneous transhepatic cholangiography; Percutaneous transhepatic bilioplasty; Bioabsorbable biliary stent

Abstract

V originále

To assess mid-term outcome of biodegradable biliary stents (BBSs) to treat benign biliary strictures refractory to standard bilioplasty. Institutional review board approval was obtained and patient consent was waived. 107 patients (61 males, 46 females, mean age 59 +/- 16 years), were treated. Technical success and complications were recorded. Ninety-seven patients (55 males, 42 females, aged 57 +/- 17 years) were considered for follow-up analysis (mean follow-up 23 +/- 12 months). Fisher's exact test and Mann-Whitney U tests were used and a Kaplan-Meier curve was calculated. The procedure was always feasible. In 2/107 cases (2 %), stent migration occurred (technical success 98 %). 4/107 patients (4 %) experienced mild haemobilia. No major complications occurred. In 19/97 patients (18 %), stricture recurrence occurred. In this group, higher rate of subsequent cholangitis (84.2 % vs. 12.8 %, p = 0.001) and biliary stones (26.3 % vs. 2.5 %, p = 0.003) was noted. Estimated mean time to stricture recurrence was 38 months (95 % C.I 34-42 months). Estimated stricture recurrence rate at 1, 2, and 3 years was respectively 7.2 %, 26.4 %, and 29.4 %. Percutaneous placement of a BBS is a feasible and safe strategy to treat benign biliary strictures refractory to standard bilioplasty, with promising results in the mid-term period. aEuro cent Percutaneous placement of a BBS is 100 % feasible. aEuro cent The procedure appears free from major complications, with few minor complications. aEuro cent BBSs offer promising results in the mid-term period. aEuro cent With a BBS, external catheter/drainage can be removed early. aEuro cent BBSs represent a new option in treating benign biliary stenosis.

Citovat

MAURI, G., C. MICHELOZZI, F. MELCHIORRE, D. PORETTI, V. PEDICINI, M. SALVETTI, E. CRIADO, J.F. FAGES, MA DE GREGORIO, A. LABORDA, L.M. SONFIENZA, G. CORNALBA, L. MONFARDINI, Jiří PÁNEK, Tomáš ANDRAŠINA and M. GIMENEZ. Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. European Radiology. New York: Springer, 2016, vol. 26, No 11, p. 4057-4063. ISSN 0938-7994. Available from: https://dx.doi.org/10.1007/s00330-016-4278-6.

@article{1375694,
   author = {Mauri, G. and Michelozzi, C. and Melchiorre, F. and Poretti, D. and Pedicini, V. and Salvetti, M. and Criado, E. and Fages, J.F. and De Gregorio, MA and Laborda, A. and Sonfienza, L.M. and Cornalba, G. and Monfardini, L. and Pánek, Jiří and Andrašina, Tomáš and Gimenez, M.},
   article_location = {New York},
   article_number = {11},
   doi = {http://dx.doi.org/10.1007/s00330-016-4278-6},
   keywords = {Biliary stricture; Percutaneous transhepatic cholangiography; Percutaneous transhepatic bilioplasty; Bioabsorbable biliary stent},
   language = {eng},
   issn = {0938-7994},
   journal = {European Radiology},
   title = {Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients},
   volume = {26},
   year = {2016}
}

TY  - JOUR
ID  - 1375694
AU  - Mauri, G. - Michelozzi, C. - Melchiorre, F. - Poretti, D. - Pedicini, V. - Salvetti, M. - Criado, E. - Fages, J.F. - De Gregorio, MA - Laborda, A. - Sonfienza, L.M. - Cornalba, G. - Monfardini, L. - Pánek, Jiří - Andrašina, Tomáš - Gimenez, M.
PY  - 2016
TI  - Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients
JF  - European Radiology
VL  - 26
IS  - 11
SP  - 4057-4063
EP  - 4057-4063
PB  - Springer
SN  - 09387994
KW  - Biliary stricture
KW  - Percutaneous transhepatic cholangiography
KW  - Percutaneous transhepatic bilioplasty
KW  - Bioabsorbable biliary stent
N2  - To assess mid-term outcome of biodegradable biliary stents (BBSs) to treat benign biliary strictures refractory to standard bilioplasty. Institutional review board approval was obtained and patient consent was waived. 107 patients (61 males, 46 females, mean age 59 +/- 16 years), were treated. Technical success and complications were recorded. Ninety-seven patients (55 males, 42 females, aged 57 +/- 17 years) were considered for follow-up analysis (mean follow-up 23 +/- 12 months). Fisher's exact test and Mann-Whitney U tests were used and a Kaplan-Meier curve was calculated. The procedure was always feasible. In 2/107 cases (2 %), stent migration occurred (technical success 98 %). 4/107 patients (4 %) experienced mild haemobilia. No major complications occurred. In 19/97 patients (18 %), stricture recurrence occurred. In this group, higher rate of subsequent cholangitis (84.2 % vs. 12.8 %, p = 0.001) and biliary stones (26.3 % vs. 2.5 %, p = 0.003) was noted. Estimated mean time to stricture recurrence was 38 months (95 % C.I 34-42 months). Estimated stricture recurrence rate at 1, 2, and 3 years was respectively 7.2 %, 26.4 %, and 29.4 %. Percutaneous placement of a BBS is a feasible and safe strategy to treat benign biliary strictures refractory to standard bilioplasty, with promising results in the mid-term period. aEuro cent Percutaneous placement of a BBS is 100 % feasible. aEuro cent The procedure appears free from major complications, with few minor complications. aEuro cent BBSs offer promising results in the mid-term period. aEuro cent With a BBS, external catheter/drainage can be removed early. aEuro cent BBSs represent a new option in treating benign biliary stenosis.
ER  -

MAURI, G., C. MICHELOZZI, F. MELCHIORRE, D. PORETTI, V. PEDICINI, M. SALVETTI, E. CRIADO, J.F. FAGES, MA DE GREGORIO, A. LABORDA, L.M. SONFIENZA, G. CORNALBA, L. MONFARDINI, Jiří PÁNEK, Tomáš ANDRAŠINA and M. GIMENEZ. Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. \textit{European Radiology}. New York: Springer, 2016, vol.~26, No~11, p.~4057-4063. ISSN~0938-7994. Available from: https://dx.doi.org/10.1007/s00330-016-4278-6.

Detailed Information on Publication Record